OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression

Detalles Bibliográficos
Autores principales: Moran, Amy, Polesso, Fanny, Weinberg, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288330/
http://dx.doi.org/10.1186/2051-1426-2-S3-O18
_version_ 1782351948322701312
author Moran, Amy
Polesso, Fanny
Weinberg, Andrew
author_facet Moran, Amy
Polesso, Fanny
Weinberg, Andrew
author_sort Moran, Amy
collection PubMed
description
format Online
Article
Text
id pubmed-4288330
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42883302015-01-15 OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression Moran, Amy Polesso, Fanny Weinberg, Andrew J Immunother Cancer Oral Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288330/ http://dx.doi.org/10.1186/2051-1426-2-S3-O18 Text en Copyright © 2014 Moran et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Moran, Amy
Polesso, Fanny
Weinberg, Andrew
OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
title OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
title_full OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
title_fullStr OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
title_full_unstemmed OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
title_short OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
title_sort ox40 agonist immunotherapy expands tumor reactive cd8 t cells with a unique t cell receptor repertoire and synergizes with pdl-1 blockade to promote tumor regression
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288330/
http://dx.doi.org/10.1186/2051-1426-2-S3-O18
work_keys_str_mv AT moranamy ox40agonistimmunotherapyexpandstumorreactivecd8tcellswithauniquetcellreceptorrepertoireandsynergizeswithpdl1blockadetopromotetumorregression
AT polessofanny ox40agonistimmunotherapyexpandstumorreactivecd8tcellswithauniquetcellreceptorrepertoireandsynergizeswithpdl1blockadetopromotetumorregression
AT weinbergandrew ox40agonistimmunotherapyexpandstumorreactivecd8tcellswithauniquetcellreceptorrepertoireandsynergizeswithpdl1blockadetopromotetumorregression

Ejemplares similares